sb 203580 has been researched along with rutecarpine in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (rutecarpine) | Trials (rutecarpine) | Recent Studies (post-2010) (rutecarpine) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 235 | 1 | 125 |
Protein | Taxonomy | sb 203580 (IC50) | rutecarpine (IC50) |
---|---|---|---|
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.23 | |
Cytochrome P450 1A1 | Homo sapiens (human) | 0.26 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.022 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 8.7 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.29 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 0.055 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bhavan, PS; Chung, CL; Hou, SM; Hsia, CH; Hsia, CW; Huang, WC; Jayakumar, T; Sheu, JR; Wu, MP | 1 |
1 other study(ies) available for sb 203580 and rutecarpine
Article | Year |
---|---|
Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB.
Topics: Animals; Disease Models, Animal; Fibrinolytic Agents; Free Radical Scavengers; Free Radicals; Humans; I-kappa B Kinase; Imidazoles; Indole Alkaloids; Male; Mice, Inbred ICR; NF-kappa B; Nitriles; P-Selectin; p38 Mitogen-Activated Protein Kinases; Platelet Activation; Protein Kinase Inhibitors; Pulmonary Embolism; Pyridines; Quinazolines; Sulfones; Thrombosis; Transcription Factor RelA | 2022 |